A Breakthrough..........

It is with some pride that we announce the availability to United States residents, for the first time, of the O'Neil Long Acting Naltexone Implant or "OLANI", from Australian addiction expert, DR. GEORGE O'NEIL, at our America's base in the Bahamas.

​

Dr. O'Neil's implant is a break-through product. It is substantially longer acting - plus or minus a year typically - and it delivers a more constant, spike-free, flow of naltrexone than contenders made in Europe, Asia and the United States, be they daily, monthly or bi-monthly in duration. This is very important because it is these spikes which cause untoward side effects, including nausea, headaches, anxiety and depression. No such side effects are experienced with the OLANI.

​

In clinical trials undertaken in Australia, more than 90% of opiate addicts were clean after 9 months, and 77% of alcoholics were not drinking at all after 6 months, with the remainder drinking only one or two drinks at a sitting.

These results are dramatically better than those achieved by any other protocol available in the States.

​

Clinical trials leading to FDA Approval in the United States were agreed in August 2018, with one of it's most prestigious research institutions, Columbia University. For strategic reasons trials will feature 6 month periodicity using less naltrexone than is typically used by the Naltrexone Implant Center or Dr. O'Neil.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Funding is now in place. The US Government (NIDA) has put up the money...

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​